South Africa can afford antiretroviral treatment
Based on existing resources, South Africa can 'easily afford' to provide anti-retroviral therapy to between 60 000 and 70 000 people in the next five years. This was the conclusion from a study by Dr Chris Kenyon of the Health Systems Trust and Dr Andrew Boulle, a registrar in the School of Public Health at the University of Cape Town, presented at the 14th World Conference on AIDS in Barcelona yesterday (Tuesday).


